MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer

Abstract Background Recent evidence indicated that the aberrant expression of microRNA plays a crucial role in the development of cervical cancer. The overall shorter survival was strongly related to the abnormal expression of microRNA-34a (miR-34a) and microRNA-206 (miR-206), which target B cell ly...

Full description

Bibliographic Details

Published in:	Cancer Cell International
Main Authors:	Ai-Hua Chen, Yu-E Qin, Wen-Fan Tang, Jing Tao, Hua-mei Song, Manzhen Zuo
Format:	Article
Language:	English
Published:	BMC 2017-06-01
Subjects:	MiR-34a MiR-206 qRT-PCR Cervical cancer
Online Access:	http://link.springer.com/article/10.1186/s12935-017-0431-9